Role of angiotensin converting enzyme, paraoxonase 1 55,192 gene polymorphisms in syndrome X and coronary heart disease

Pakistan Journal of Biological Sciences

Volumn 12, Issue 1, 2009, Pages 46-51

  Sesal, C ^a   Ciloglu, F ^b   Peker, I ^c   Sayar, N ^d  

^a MARMARA UNIVERSITY   (Turkey)

^b GenLab Genetic Medical Laboratories Istanbul   (Turkey)

^c CYPRUS INTERNATIONAL UNIVERSITY   (Turkey)

^d DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Angiotensin converting enzyme; Coronary heart disease; Genetic polymorphism; Paraoxonase 1; Syndrome X

Indexed keywords

ARYLDIALKYLPHOSPHATASE; DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CORONARY ARTERY DISEASE; ENZYMOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; METABOLIC SYNDROME X; RISK FACTOR;

ARYLDIALKYLPHOSPHATASE; CORONARY DISEASE; GENE FREQUENCY; GENOTYPE; HUMANS; METABOLIC SYNDROME X; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 60549084919     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2009.46.51     Document Type: Article

References (30)

1. Adkins, S., K.N. Gan, M. Mody and B.N. La Du, 1993. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Glutamine or arginine at position 191, for the respective A or B allozymes. Am. J. Hum. Genet., 52: 598-608.
2. Agachan, B., H. Yilmaz, Z. Karaah and T. Isbir, 2004. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus. Cell Biochem. Funct, 22: 163-168.
3. Antikainen, M., S. Murtomäki, M. Syvänne, R. Pahlman and E. Tahvanainen et at, 1996. The Gln-Argl91 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in firms. J. Clin. Invest. 98: 883-885.
4. Aviram, M., E. Hardak, I. Vaya, S. Mahmood and S. Milo et at, 2000. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase andperoxidase-like activities. Circulation, 101: 2510-2517.
5. Berkovich, O.A., E.A. Bazhenova, E.A. Volkova, M.Z. Alugishvih and I.O. Kiselev et al., 2001. I/D polymorphism in the angiotensin-converting enzyme gene in men with myocardial infarction at young age. Ross Fiziol Zh Im I M Sechenova, 87: 642-648.
6. Covolo, L., U. Gelatti, M. Metra, F. Donato and S. Nodari et al., 2003. Angiotens in-converting enzyme gene polymorphism and heart failure: A case control study. Biomarkers, 8: 429-436.
7. Dakik, H.A., J.J. Mahmarian, M.S. Verani, J.A. Farmer, G. Zhao and A.J. Marian, 1997. Association of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarctrelated artery in patients with acute myocardial infarction. J. Am. Coll. Cardiol, 29: 1468-1473.
8. Deng, J., Y. Zhou, D. Huang, J. Yue, Y. Wang, X. Zhang and D. Xie, 2002. Relation between coronary artery disease and polymorphism of angiotensin converting enzyme gene. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 19: 105-107.
9. Eichner, J.E., V.J. Christiansen, W.E. Moore, S.T. Dunn and E. Schechter, 2001. Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients. Atherosclerosis, 154: 673-679.
10. Esparragon, F., A.D. Espinosa, A.M. Fernandez-Aceituno, F. Nuez and E.H. Ortega et al., 2002. The involvement of the rennin angiotensin system gene polymorphisms in coronary artery disease. Heart Disease, 55: 92-99.
11. Fatini, C, R. Abbate, G. Pepe, B. Battaglini and F. Gensini et al., 2000. Searching for a better assessment of the individual coronary risk profile. The role of angiotens in-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms. Eur. Heart J., 21: 633-638.
12. Gardemann, A., M. Philipp, K. Hess,N. Katz, H. Tillmanns and W. Haberbosch, 2000. The paraoxonase Leu- Met54 and Gln-Argl91 gene polymorphisms are not associated with the risk of coronary heart disease. Atherosclerosis, 152: 421-431.
13. Hubacek, J.A., J. Pitha, I. Podrapská, J. Sochman, V. Adámková, V. Lánská and R. Poledne, 2000. Insertion/deletion polymorphism in the angiotensin converting enzyme gene in myocardial infarction survivors. Med. Sci. Monit, 6: 503-506.
14. Humbert, R., D.A. Adler, CM. Disteche, C. Hassett, C.J. Omiecinski and C.E. Furlong, 1993. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet, 3: 73-76.
15. Imai, Y., H. Morita, H. Kurihara, T. Sugiyama and N. Kato et al., 2000. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis, 149: 435-442.
16. Lim, S.C, B.Y. Tan, S.K. Chew and C.E. Tan, 2002. The relationship between insulin resistance and cardiovascular risk factors in overweight/obese non diabetic Asian adults: The 1992 Singapore national health survey. Int. J. Obes. Relat. Metab. Disord., 26: 1511-1516.
17. Lindpainther, K., M.A. Pfeffer, R. Kreutz, M.J. Stampfer, F. Grodstein and F. La Motte, 1995. A prospective evaluation of an angiotensin converting enzyme gene polymorphism and the risk of ischemic heart disease. New England Med., 332: 706-711.
18. Mansur, A.P., J. Annicchino-Bizzacchi, D. Favarato, S.D. Avakian L.A. César and J.A. Ramires, 2000. Angiotensin-converting enzyme and apolipoproteins genes polymorphism in coronary artery disease. Clin. Cardiol., 23: 335-340.
19. Mattu, R.K., E.W. Needham, D.J. Galton, E. Frangos, A.J. Clark and M. Caulfield, 1995. A DNA variant at the angiotens in-converting enzyme gene locus associates with coronary artery disease in the caerphilly heart study. Circulation, 91: 270-274.
20. Nagi, D.K., C.A. Foy, V. Mohamed-Ali, J.S. Yudkin, P.J. Grant and W.C. Knowler, 1998. Angiotensin-1 converting enzyme (ACE) gene polymorphism, plasma ACE levels and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians. Metabolism, 47: 622-626.
21. Norman, N.C., P.S.K. Alice and C.N.C. Juliana, 2005. Metabolic syndrome and type 2 diabetes: The Hong Kong perspective. Clin. Biochem. Rev., 26: 51-57.
22. Olivera, S.A., A.P. Mansur, C.C. Ribeiro, J.A. Ramires and J.M. Anmchino-Bizzacchi, 2004. PON1 M/L 55 mutation protects high- risk patients against coronary heart disease. Int. J. Cardiol, 94: 73-77.
23. Rigat, B., C. Hubert, F. Alhenc-Gelas, F. Cambien, P. Corvol and F. Soubrier, 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest, 86: 1343-1346.
24. Schmidt H., R. Schmidt, K. Niederkorn, A. Gradert and M. Schumacher et al., 1998. Paraoxonase PON1 polymorphism Ieu-Met54 is associated with carotid atherosclerosis: Results of the Austrian stroke prevention study. Stroke, 29: 2043-2048.
25. Shadrina, M.I., P.A. Slominskii, O.V. Miloserdova, N. V. Perova and S.A. Limborskaia, 2001. Polymorphism of the angiotens in-converting enzyme gene in patients with coronary heart disease from Moscow population. Genetika, 37: 540-544.
26. Suehiro, T., Y. Nakauchi, M. Yamamoto, K. Arii, H. Itoh, N. Hamashige and K. Hashimoto, 1996. Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease. Int. J. Cardiol, 57: 69-73.
27. Thomas, G.N., B. Tomlinson, J.C. Chan, J.E. Sanderson, C.S. Cockram and J.A. Critchley, 2001. Renin angiotensin system gene polymorphisms, blood pressure, dyslipidemia and diabetes in Hong Kong Chinese: A significant association of the ACE insertion/deletion polymorphism with type 2 diabetes. Diabetes Care, 24: 356-361.
28. Uemura, K., J. Nakura, K. Kohara and T. Mrki, 2000. Association of ACE I/D polymorphism with cardiovascular risk factors. Hum. Genet, 107: 239-342.
29. Watzinger, N., H. Schmidt, M. Schumacher, R. Schmidt and B. Eber et al., 2002. Human paraoxonase 1 gene polymorphisms and the risk of coronary heart disease: A community-based study. Cardiology, 98: 116-122.
30. Zaman, M., N. Yoshiike, C. Date, T. Yokoyama, Y. Matsumara, S. Ikemoto and H. Tanaka, 2001. ACE genetic polymorphism is not associated with hypertension in cross sectional sample of a Japanese population. J. Hypertensive, 19: 47-53.